Lorraine Kelly replaced by Carol Vorderman on ITV show after testing positive for Covid
Lorraine Kelly confirmed Carol Vorderman will be filling in for her after she has tested positive for Covid-19.
Good Morning Britain hosts Susanna Reid and Ed Balls introduced her replacement during their own show on Monday, as Carol confirmed what was coming up on the show. Carol stepped in to host at the last minute, and even Susanna confessed she didn't think she was hosting the show until she spotted her in the studio.
Susanna said: "Yes, get well soon Lorraine," as Carol echoed: "Get well soon." Carol then joked: "I didn't look like this at five o'clock this morning, that is for sure!" One wrote: "Get better soon and enjoy the puppy cuddles. Feel your pain currently and thank god for the vaccines. Mowdie and Midge send their love" Another penned: "So sorry to read this hope you’re ok. Wishing you a speedy recovery X"
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Lorraine Kelly forced to miss ITV show after testing positive for Covid-19No Lorraine Kelly this morning as she tests positive for Covid-19 - We hope you get better soon Lorraine 💖
Read more »
Key characteristics impacting survival of COVID-19 extracorporeal membrane oxygenation - Critical CareBackground Severe COVID-19 induced acute respiratory distress syndrome (ARDS) often requires extracorporeal membrane oxygenation (ECMO). Recent German health insurance data revealed low ICU survival rates. Patient characteristics and experience of the ECMO center may determine intensive care unit (ICU) survival. The current study aimed to identify factors affecting ICU survival of COVID-19 ECMO patients. Methods 673 COVID-19 ARDS ECMO patients treated in 26 centers between January 1st 2020 and March 22nd 2021 were included. Data on clinical characteristics, adjunct therapies, complications, and outcome were documented. Block wise logistic regression analysis was applied to identify variables associated with ICU-survival. Results Most patients were between 50 and 70 years of age. PaO2/FiO2 ratio prior to ECMO was 72 mmHg (IQR: 58–99). ICU survival was 31.4%. Survival was significantly lower during the 2nd wave of the COVID-19 pandemic. A subgroup of 284 (42%) patients fulfilling modified EOLIA criteria had a higher survival (38%) (p = 0.0014, OR 0.64 (CI 0.41–0.99)). Survival differed between low, intermediate, and high-volume centers with 20%, 30%, and 38%, respectively (p = 0.0024). Treatment in high volume centers resulted in an odds ratio of 0.55 (CI 0.28–1.02) compared to low volume centers. Additional factors associated with survival were younger age, shorter time between intubation and ECMO initiation, BMI | 35 (compared to | 25), absence of renal replacement therapy or major bleeding/thromboembolic events. Conclusions Structural and patient-related factors, including age, comorbidities and ECMO case volume, determined the survival of COVID-19 ECMO. These factors combined with a more liberal ECMO indication during the 2nd wave may explain the reasonably overall low survival rate. Careful selection of patients and treatment in high volume ECMO centers was associated with higher odds of ICU survival. Trial registration Registered in the German Clinical Trials Re
Read more »
Omicron Booster Jabs On Horizon As Covid Cases And Hospitalisations ClimbAn estimated one in 30 of us has Covid, leading to renewed calls for booster jabs from health experts.
Read more »
Covid-19 vaccines saved an estimated 20m lives during their first yearAs bad as the past 18 months have been, they would have been worse without vaccines—perhaps about 2.7 times worse
Read more »